Schedule 13G ownership disclosure

Corvus Pharmaceuticals Inc

COMMON STOCK · CUSIP: 221015100

Event date: 2026-09-30

Filing-level shares
3,331,535.00
Percent of class
4%
  • STATE STREET CORPORATION

    Shares: 3,331,535.00 · Class: 4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-26-000636
Form type
SCHEDULE 13G
Filer
Corvus Pharmaceuticals, Inc.
CIK
CIK 1626971
Filed
Nov 10, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub